Vigitest, a device that allows an assessment of workers vigilance during worktimeDujardin, Marc ; Poirrier, Robert ; Mairiaux, Philippe ![]() Poster (2006, June) Detailed reference viewed: 13 (5 ULg) A stepwise approach for chemical risks assessment at the workplaceMairiaux, Philippe ; ; Dujardin, Marc et alin Strasser, H.; Kluth, K.; Rausch, H. (Eds.) et al Quality of work and products in enterprises of the future (2003) Detailed reference viewed: 12 (2 ULg) Sma Circuits Reduce Platelet Consumption and Platelet Factor Release During Cardiac SurgeryDefraigne, Jean-Olivier ; Pincemail, Joël ; Dekoster, Guy et alin Annals of Thoracic Surgery (2000), 70(6), 2075-81 BACKGROUND: Platelet count and function are particularly damaged by cardiopulmonary bypass (CPB). This study evaluated the effects of a novel CPB circuit in terms of platelet count and activation, and ... [more ▼] BACKGROUND: Platelet count and function are particularly damaged by cardiopulmonary bypass (CPB). This study evaluated the effects of a novel CPB circuit in terms of platelet count and activation, and postoperative need for blood products. METHODS: One hundred patients undergoing coronary grafting were randomized in two groups: control group (n = 50) and test group (n = 50, surface modifying additives circuit, SMA group). Blood samples were taken before, during, and after CPB. Postoperative blood loss, number of transfused blood products, and postoperative variables were recorded. RESULTS: The platelet count decreased less in the SMA group compared to the control group (end of CPB: respectively, 165 +/- 9 x 10(3)/mm3 vs 137 +/- 8 x 10(3)/mm3; p < 0.01). This was paralleled by a reduction in beta-thromboglobulin plasma levels in the SMA group. There was a trend to decreased blood loss in the SMA group, but the difference was significant only in patients taking aspirin preoperatively (p < 0.05). In the SMA group nearly 50% less fresh frozen plasma and platelet units were administered (p < 0.01). No operative deaths were observed. CONCLUSIONS: The use of circuits with surface additives is clinically safe, preserves platelet levels, and attenuates platelet activation. This may lead to a reduced need for blood products. [less ▲] Detailed reference viewed: 13 (0 ULg) |
||